Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0017638 (glioma)
 30,880 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

There are conflicting reports in connection with the association of the p53 tumour suppressor gene mutation with the clinical and histopathological progression of gliomas. Glia-derived neoplasms frequently show mutational changes in the p53 gene which result in enhancement of tumorigenesis. The aim of the paper was an assessment of the frequency of mutations in the exon 8 of this gene. The specimens from 14 patients operated for glial tumors were investigated by polymerase chain reaction-assisted--single strand conformation polymorphism (PCR-SSCP). We found aberrant bands in 64.3% of specimens. The percentage of mutations was similar in patients with benign and malignant tumours. There was no correlation between the alteration of the gene and intensity of necrosis in histological examination in patients with glioblastoma. Changes in activity of the p53 gene were more frequent in younger patients and in males when compared to women.
Neurol Neurochir Pol 2001
PMID:[Assessment of p53 dependent apoptosis in glia-derived tumors of the brain]. 1193 77

In this review we summarize the present status of our knowledge on the enzymes involved in the extracellular metabolism of nucleotides and the receptors involved in nucleotide signalling. We focus on the mechanism of the ATP and ADP signalling pathways in glioma C6, representative of the type of nonexcitable cells. In these cells, ATP acts on the P2Y(2) receptor coupled to phospholipase C, whereas ADP on two distinct P2Y receptors: P2Y(1) and P2Y(12). The former is linked to phospholipase C and the latter is negatively coupled to adenylyl cyclase. The possible cross-talk between the ATP-, ADP- and adenosine-induced pathways, leading to simultaneous regulation of inositol 1,4,5-trisphosphate and cAMP mediated signalling, is discussed.
Acta Biochim Pol 2002
PMID:Cross-talk between the ATP and ADP nucleotide receptor signalling pathways in glioma C6 cells. 1254 94

We aimed to assess the effect of three drugs belonging to amphiphilic cations, imipramine, amitriptyline and propranolol, on lipid synthesis and intracellular calcium homeostasis in glioma C6 cells. Antidepressants, imipramine and amitriptyline, had a stimulatory effect on [14C]serine incorporation into phosphatidylserine. Similar effect was induced by propranolol, antidysrhythmic drug and an antagonist of beta-adrenergic receptor, but not by isoproterenol, a selective agonist of this receptor. Stimulation of serine base-exchange activity by amphiphilic cations occured at concentration as low as 5-25 microM that may be reached during clinical treatment. At much higher concentration (250 microM), those drugs also stimulated phospholipase D-mediated synthesis of [14C]phosphatidylethanol and blocked phorbol ester-induced, protein kinase C-dependent phospholipase D activity. The latter effect already occurred at low (25 microM) concentration of drugs. We have also shown that treatment of the cells with amphiphilic cations (1 mM) produced only a weak increase in the intracellular Ca2+ concentration and did not affect Ca2+ release from the intracellular stores evoked by nucleotide receptor agonists, ATP and ADP. In contrast, this treatment strongly diminished an unspecific leak of Ca2+ from the endoplasmic reticulum caused by thapsigargin and ionomycin. Mianserin, which is not cationic amphiphilic drug, did not affect phosphatidylserine synthesis and phospholipase D activity and produced heterogenous and chaotic Ca2+ responses. Our results suggest that imipramine, amitriptyline and propranolol may modulate lipid synthesis and intracellular calcium signaling independently of their action on membrane receptors, most probably by modification of the physicochemical properties of cell membranes.
Pol J Pharmacol
PMID:Modulation by cationic amphiphilic drugs of serine base-exchange, phosholipase d and intracellular calcium homeostasis in glioma C6 cells. 1259 35

Standard therapeutic modalities including surgery, radio- and/or peripheral chemotherapy are ineffective in malignant gliomas. This is due to infiltration of distant brain areas by glioma cells and to the blood-brain barrier limiting penetration of anticancer drugs. One of the most promising experimental methods of glioma therapy is intracerebral implantation of biodegradable polymers containing cytotoxic compounds. This method allows to avoid peripheral toxicity of drugs. Considering that practically it is only malignant cells that proliferate in the brain, the use of drugs displaying selective toxicity toward DNA-replicating cells might help to avoid central toxicity as well. Several nucleoside analogs display selective cytotoxic and/or radiosensitizing effects on proliferating cells. Despite encouraging results obtained in the in vitro and animal models of gliomas, peripheral administration of these drugs turned out to be ineffective in the clinical settings. Intracerebral implantation of nucleoside analogs-containing biodegradable polymers may be much more efficacious, especially when combined with radiotherapy. Appropriate nucleoside analogs may also be employed in cell-selective radiotherapy and gene therapy of malignant gliomas.
Neurol Neurochir Pol
PMID:[Nucleoside analogs in the treatment of primary malignant brain tumors]. 1459 62

The prognosis of patients with brain gliomas remains poor despite the use of advanced surgical techniques, radio- and chemotherapy. In this respect, gene engineering techniques altering the glioma genome in order to regulate the function of key genes involved in cancerogenesis seem to be promising. The premise for applying a gene therapy in patients with brain gliomas is described, together with basic strategies and results of hitherto performed experimental and clinical studies, mostly with the use of virus vectors. The rapid progress in molecular techniques may enable to overcome methodological problems related to the introduction of the therapeutic gene into the target cell, and thus to improve so far unsatisfactory results of glioma gene therapy. The important role of a neurosurgeon in the process of precise gene vector application to the tumour area should not be underestimated.
Neurol Neurochir Pol
PMID:[Gene therapy for the treatment of patients with brain gliomas]. 1504 68

A case is presented of a 38-year-old female patient who developed bifocal metachronous cerebral glioma with the same histological appearance (glioblastoma multiforme). Two separate tumors were operated on within six months: the first one was localized in the left parieto-occipital area, and the other in the right temporal lobe. The tumor cells dissemination occurred probably via the CSF pathways: during the first operation the posterior horn of the left lateral ventricle was opened, and the second neoplastic lesion was situated also in the direct vicinity of CSF spaces (the Sylvian cistern). For all practical purposes, the case presented testifies to the necessity of intraoperative protection of the CSF spaces by separating any open CSF cisterns from the removed tumor mass with cotton pads. In case of diagnosing cerebral glioma, a possibility of the presence of multiple foci should be taken into account. It is especially important for the differentiation of multiple lesions occurring synchronically, where similarity of radiological features is seen in metastases, cerebral abscesses and demyelinating lesions.
Neurol Neurochir Pol
PMID:[Multiple cerebral glioma or tumor dissemination via CSF pathways? Case report]. 1517 43

Delta-aminolevulinic acid (ALA) is a precursor of the synthesis of porphyrins including heme produced in all mammalian cells. Exogenous ALA induces selective accumulation of the other heme precursor, protoporphyrin IX (PpIX), in neoplastic cells, such as those of malignant gliomas. Upon exposure to violet-blue light PpIX becomes activated, which results in red-light fluorescence as well, as in photodynamic oxidations which may be lethal to the cells. In neurosurgery ALA is used for intraoperative labeling of the border regions of malignant gliomas infiltrated by alive clonogenic tumor cells (ALA-PDD), and is helpful in precise resection of these regions. Clinical data indicate that ALA-PDD-assisted resection of malignant gliomas may result in statistically significant prolongation of postoperative survival. Ongoing research concentrates also on the use of ALA for a selective elimination of glioma cells in situ, and on lipophilic ALA derivatives with more favorable pharmacokinetic properties.
Neurol Neurochir Pol
PMID:[5-Aminolevulinic acid (ALA) and its applications in neurosurgery]. 1535 33

We present a case of bilateral hematoma in cerebellar hemispheres in a 30-year-old man after surgical treatment of extensive left frontal glioma. 16 hours after surgery the patient lost consciousness. An immediate CT revealed hematoma in both cerebellar hemispheres. The hematoma was subsequently removed via bilateral suboccipital craniectomy. After the operation the clinical status of the patient gradually improved - he was discharged in a good general condition. In the presented case the hematoma developed presumably as a consequence of extensive cerebrospinal fluid (CSF) loss (670 ml) via postoperative wound drainage. The resulting cerebellar displacement caused strain of the draining veins, affecting blood outflow, and causing parenchymal hemorrhage. In order to prevent the complication, massive CSF loss during and after operation should be avoided. Careful monitoring of the patient's condition in the postoperative period, even if the general status is good, is important because only an immediate intervention may prevent the development of irreversible consequences of cerebellar hematoma formation.
Neurol Neurochir Pol
PMID:[Bilateral cerebellar hematoma after supratentorial glioma surgery]. 1535 40

The authors presented a case of nasal glioma in an adult man which had performed as nasal polyp. Histopathologic studies confirmed neuroglial tissue--Astrocytoma fibrillare. These tumor cells were immunohistochemically positive for glial fibrillary acidic protein as well as for S-100 protein and vimentin. There was no communication between the tumor and the cranial cavity on radiological examination (TC, MRI). Treatment is usually surgical. In this article authors describe a case of a nasal glioma that was removed via a lateral rhinotomy.
Otolaryngol Pol 2005
PMID:[The rare case of nasal glioma]. 1627 73

In this study the contribution of the ERK1/2 pathway to sphingosine-induced death and morphological changes of the actin cytoskeleton in glioma C6 cells was investigated. Surprisingly, the level of ERK1/2 phosphorylation does not change after incubation of cells with sphingosine. Despite this, sphingosine induces rounding and detachment of cells without formation of apoptotic bodies. To shed light on this process, a specific inhibitor of ERK1/2 phosphorylation, U0126, was used. Cells incubated simultaneously with sphingosine and U0126 not only detached, but also exhibited formation of apoptotic-like blebs. These data suggest that during sphingosine-induced glioma C6 cell death apoptotic blebbing is dependent on ERK1/2 signalling and occurs only when ERK1/2 activity is decreased or abolished.
Acta Biochim Pol 2005
PMID:Modulation of ERK1/2 activity is crucial for sphingosine-induced death of glioma C6 cells. 1630 24


<< Previous 1 2 3 4 5 Next >>